The latter included six cancer-testis antigens (CTAG2, MAGEB4, MAGEA12, MAGEA4, XAGE3, BAGE4), and five other tumor-associated antigens (SHARPIN, MRFAP1L1, PNMA2, AURKA, SERPINB1). Here, SHARPIN is linked to neoplasm.